Literature DB >> 1428560

A clinical evaluation of XPERT NCT (Reichert) for glaucoma screening by optometrists.

G Hollo1, P Follmann, G Pap.   

Abstract

XPERT NCT advanced logic pneumotonometer (Reichert) was studied for its reliability and use in glaucoma screening. The evaluated 2400 NCT measurements on 300 eyes were compared to the results of Goldmann applanation tonometry (GAT) from the same eyes. Repeated NCT tonometry had no significant effect on IOP. Local anesthesia reduced mean NCT-GAT difference and standard deviation significantly (p < 0.05), i.e. feeling due to the diminished air pulse force provided by the instrument had still considerable influence on IOP. NCT-GAT regression was significant (p < 0.01). Mean IOP readings provided by NCT were four mmHg higher than GAT values. Although accuracy was not satisfactory for exact measuring, it was satisfactory for screening. The results suggested that four mmHg less than the mean IOP value seen on the display is acceptable for screening when the difference between the minimal and maximal individual readings on the display is less than 2SD i.e. six mmHg. In the case of a greater difference, the maximal value is to be replaced, as NCT tends to read higher values than GAT.

Entities:  

Mesh:

Year:  1992        PMID: 1428560     DOI: 10.1007/bf00917978

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  1 in total

1.  XPERT NCT--a clinical evaluation.

Authors:  K J Myers; P Lalle; A Litwak; S Campbell; R Ballinger; B Grolman
Journal:  J Am Optom Assoc       Date:  1990-11
  1 in total
  2 in total

1.  A comparison of four methods of tonometry: method agreement and interobserver variability.

Authors:  P-A Tonnu; T Ho; K Sharma; E White; C Bunce; D Garway-Heath
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

2.  Effect of topical corneal anaesthesia on ocular response analyzer parameters: pilot study.

Authors:  A Ehongo; V De Maertelaer; S Pourjavan
Journal:  Int Ophthalmol       Date:  2008-06-11       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.